Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Using radiolabeled glass beads to kill tumor cells may be effective treatment for liver cancer that cannot be removed by surgery.
| Study Type: |
Observational |
| Estimated Enrollment: |
500 participants |
| Observational Model: |
Cohort |
| Time Perspective: |
Prospective |
| Official Title: |
A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma |
| Actual Study Start Date: |
December 2004 |
| Estimated Primary Completion Date: |
January 2020 |
| Estimated Study Completion Date: |
January 2021 |
Contact
| Contact: Clinical Trials Office - Robert H. Lurie Comprehensive Cancer 312-695-1301 cancertrials@northwestern.edu |
| ClinicalTrials.gov Identifier: |
NCT00530010 |
For enrollment please visit www.clinicaltrials.gov.
